Apeiron Capital Investment Corp. announced the pricing of its $150 million IPO and its units are expected to begin trading on the NYSE under the symbol “APN.U” Tuesday, November 9.
The new SPAC intends to focus its search on companies in the financial technology, media, gaming and financial services (“FTMG”) and in the wealth-advisory and asset management industries. Apeiron Capital Investment Corp. is led by Chairman and CEO Joel Shulman, COO Eva Adosoglou, and CFO Grant Grigorian.
Total SPAC deal count for 2021 year-to-date is now 528. This offering is expected to close on Thursday, November 11.
Cantor Fitzgerald & Co. is acting as sole book-running manager of the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with King & Spalding LLP serving as Underwriter’s Counsel. Marcum, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...
At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...